Roche has revealed new results from a phase 2 trial of its oral BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS) that suggest it can prevent progression of the disease for nearly two ...

When it comes to cloud storage, not all storage systems work the same way. Two of the most widely used storage architectures ...

Learn why Forrester estimates a 230% ROI of Atlassian Cloud Enterprise in The Total Economic Impact study – thanks to improved efficiency, accelerated decision-making, and greater scalability. The ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...